Page last updated: 2024-11-03

promethazine and Mitochondrial Diseases

promethazine has been researched along with Mitochondrial Diseases in 1 studies

Promethazine: A phenothiazine derivative with histamine H1-blocking, antimuscarinic, and sedative properties. It is used as an antiallergic, in pruritus, for motion sickness and sedation, and also in animals.
promethazine : A tertiary amine that is a substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropan-2-amine moiety.

Mitochondrial Diseases: Diseases caused by abnormal function of the MITOCHONDRIA. They may be caused by mutations, acquired or inherited, in mitochondrial DNA or in nuclear genes that code for mitochondrial components. They may also be the result of acquired mitochondria dysfunction due to adverse effects of drugs, infections, or other environmental causes.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Narayanan, MV1
Zhang, W1
Stavrovskaya, IG1
Kristal, BS1
Friedlander, RM1

Other Studies

1 other study available for promethazine and Mitochondrial Diseases

ArticleYear
Promethazine: a novel application as a neuroprotectant that reduces ischemia-mediated injury by inhibiting mitochondrial dysfunction.
    Clinical neurosurgery, 2004, Volume: 51

    Topics: Animals; Blotting, Western; Brain Ischemia; Cell Death; Cerebral Cortex; Histamine H1 Antagonists; I

2004